SPEC
NEUTRALInspecs Group Grants CEO Share Options
The healthcare company has granted share options to its Chief Executive Officer.
INSPECS Group
49.50GBX
0.00%
Market Cap
50.33M
Volume
3.58k
1% of avg
P/E Ratio
7.07
EPS (TTM)
0.07
Beta
2.19
Day Range
48.55p - 48.55p
52 Week Range
37.00p49.50p62.25p
49.50p
Upcoming Events
2027
Maturity of new loan facilities
SPEC
NEUTRALInspecs Group Provides AGM Update
The eyewear manufacturer provides an update on current trading and its strategic review, but does not report any significant financial or operational news.
SPEC
NEUTRALInspecs Group Announces Board Changes and General Meeting Update
The retailer announces changes to its board composition, including the departure of the Executive Chair, and provides an update on a general meeting requisition.
SPEC
NEUTRALINSPECS Group Announces Director Shareholding Change
The retailer has announced a change in director shareholding.
SPEC
NEUTRALInspecs Group Responds to Requisition for General Meeting
The retailer responds to a requisition for a general meeting, rejecting proposals to remove the current Executive Chair and appoint a new director.
SPEC
NEUTRALINSPECS Group Announces Holding Change
The retailer has announced a change in its shareholding structure.
SPEC
NEUTRALINSPECS Group Provides Annual Report and AGM Notice
The retailer has announced the posting of its annual report and notice of the upcoming annual general meeting.
SPEC
NEUTRALINSPECS Group Announces Board Update
The retailer announces a non-executive director is stepping down to take on a new role elsewhere.
SPEC
NEUTRALInspecs Announces CFO Succession
The retailer announces its Chief Financial Officer will step down, with the Board initiating a search for a successor.
SPEC
BADINSPECS Reports Mixed Results Amid Challenging Market Conditions
The eyewear designer and manufacturer faced headwinds, reporting a loss before tax and revenue decline. Despite some operational improvements, challenges persist in consumer demand and market conditions.